4.7 Article

Targeted inactivation of the COP9 signalosome impairs multiple stages of T cell development

Journal

JOURNAL OF EXPERIMENTAL MEDICINE
Volume 205, Issue 2, Pages 465-477

Publisher

ROCKEFELLER UNIV PRESS
DOI: 10.1084/jem.20070725

Keywords

-

Funding

  1. NHLBI NIH HHS [R01 HL43331, R01 HL043331] Funding Source: Medline
  2. Telethon [TGT06S01] Funding Source: Medline
  3. Associazione Italiana per la Ricerca sul Cancro Funding Source: Custom

Ask authors/readers for more resources

Genetic programs promoting cell cycle progression, DNA repair, and survival are coordinately induced in developing T cells and require rapid turnover of effector molecules. As the COP9 signalosome (CSN) has been placed at the crossroads of these programs in lower organisms, we addressed its role by conditionally deleting CSN5/JAB1, its catalytic subunit, in developing thymocytes. CSN5/JAB1(del/del) thymocytes show defective S phase progression and massive apoptosis at the double-negative (DN)4-double-positive (DP) transition stage, which is paralleled by altered turnover of selected CSN-controlled substrates, including p53,I kappa B-alpha, and beta-catenin. Combined dysregulation of the p53 and NF-kappa B pathways affects thymocyte survival by altering the mRNA and protein levels of selected Bcl-2 family members. Genetic complementation analysis performed on p53(-/-), Bcl-xL/Bcl-2A1, or T cell receptor transgenic backgrounds indicates that CSN5/JAB1 acts at distinct developmental stages to coordinate proliferation, survival, and positive selection of thymocytes by controlling the induction of defined genetic programs acting downstream of CSN-regulated transcription factors.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available